Cargando…

Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids

OBJECTIVE: Ghrelin regulates body weight, food intake, and blood glucose. It also regulates insulin secretion from pancreatic islet cells. LEAP2 is a newly discovered endogenous ligand of the growth hormone secretagogue’s receptor (GHSR). It not only antagonizes the stimulation of GHSR by ghrelin bu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiaxi, Huang, Pu, Xiong, Jing, Liang, Xinyue, Li, Mei, Ke, Hao, Chen, Chunli, Han, Yang, Huang, Yanhong, Zhou, Yan, Luo, Ziqiang, Feng, Dandan, Chen, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175609/ https://www.ncbi.nlm.nih.gov/pubmed/35521798 http://dx.doi.org/10.1530/EC-22-0012

Ejemplares similares

LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity
por: Lu, Xuehan, et al.
Publicado: (2021)

The role of dysregulated ghrelin/LEAP-2 balance in anorexia nervosa
por: Tezenas du Montcel, Chloé, et al.
Publicado: (2023)

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
por: Shankar, Kripa, et al.
Publicado: (2021)

“A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”
por: Gupta, Deepali, et al.
Publicado: (2020)

Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2
por: Holm, Stephanie, et al.
Publicado: (2022)

Study of the Ghrelin/LEAP-2 Ratio in Humans and Rats during Different Phases of Pregnancy
por: Garcés, Maria Fernanda, et al.
Publicado: (2022)

LEAP‐2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study
por: Vergani, Edoardo, et al.
Publicado: (2021)

The role of dysregulated ghrelin/LEAP-2 balance in eating disorder: a translational study in anorexia nervosa.
por: Tezenas du Montcel, C.
Publicado: (2023)

The role of dysregulated ghrelin/LEAP-2 balance in eating disorder: a translational study in anorexia nervosa
por: Tezenas du Montcel, C., et al.
Publicado: (2023)

LEAP-2 Counteracts Ghrelin-Induced Food Intake in a Nutrient, Growth Hormone and Age Independent Manner
por: Lugilde, Javier, et al.
Publicado: (2022)

OR12-04 LEAP2 Deletion Does Not Counteract The Effects Of Ghrelin Deletion During Insulin-Induced-Hypoglycemia
por: Shankar, Kripa, et al.
Publicado: (2023)

PMON253 The Ghrelin/Leap-2 ratio might be associated with physiologic changes in maternal weight during different stages of pregnancy
por: Buell-Acosta, Julieth Daniela, et al.
Publicado: (2022)

Emerging organoid models: leaping forward in cancer research
por: Fan, Han, et al.
Publicado: (2019)

Acylated- and unacylated ghrelin during an oral glucose tolerance test in humans at risk for type 2 diabetes mellitus
por: Wolf, Magnus, et al.
Publicado: (2023)

Circulating LEAP-2 Levels in Adult Growth Hormone Deficiency and Their Relationship With IGF-1
por: Vergani, Edoardo, et al.
Publicado: (2021)

Ghrelin is a possible new predictor associated with executive function in patients with type 2 diabetes mellitus
por: Chen, Siting, et al.
Publicado: (2016)

Ghrelin regulation of glucose metabolism
por: Poher, Anne-Laure, et al.
Publicado: (2018)

Recipe for Zoonosis: How Influenza Virus Leaps into Human Circulation
por: Honce, Rebekah, et al.
Publicado: (2020)

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men
por: Hagemann, Christoffer A., et al.
Publicado: (2022)

MOSPD2 is a receptor mediating the LEAP-2 effect on monocytes/macrophages in a teleost, Boleophthalmus pectinirostris
por: Li, Chang-Hong, et al.
Publicado: (2020)

J‐LEAPS peptide and LEAPS dendritic cell vaccines
por: Rosenthal, Ken S., et al.
Publicado: (2012)

Elevated circulating ghrelin in patients with COPD: A meta-analysis
por: Zhang, Xue, et al.
Publicado: (2018)

Circulating Ghrelin Levels and Obestatin/Ghrelin Ratio as a Marker of Activity in Ulcerative Colitis
por: Jung, Ja Young, et al.
Publicado: (2015)

Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9)
por: Wang, Yu, et al.
Publicado: (2016)

TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN
por: Zhang, Kaini, et al.
Publicado: (2023)

LEAP LEAR
Publicado: (1996)

Leaps in genetics
por: Damle, S. G.
Publicado: (2010)

Quantum leaps
por: Bernstein, Jeremy
Publicado: (2009)

LEAP-Based Greenhouse Gases Emissions Peak and Low Carbon Pathways in China’s Tourist Industry
por: Liu, Dandan, et al.
Publicado: (2021)

LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?
por: Liu, Dan, et al.
Publicado: (2022)

Acylated Ghrelin and The Regulation of Lipid Metabolism in The Intestine
por: Auclair, N., et al.
Publicado: (2019)

Allosteric modulation of ghrelin receptor signaling by lipids
por: Damian, Marjorie, et al.
Publicado: (2021)

Relationship Between Acyl and Desacyl Ghrelin Levels with Insulin Resistance and Body Fat Mass in Type 2 Diabetes Mellitus
por: Zang, Pu, et al.
Publicado: (2022)

Ghrelin Receptor Is Required for the Effect of Nesfatin-1 on Glucose Metabolism
por: Fan, Xin-Tong, et al.
Publicado: (2018)

Perfmon2: a leap forward in performance monitoring
por: Jarp, S, et al.
Publicado: (2008)

Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
por: Srinivasan, Mythily, et al.
Publicado: (2018)

Leap motion for developers
por: Nandy, Abhishek
Publicado: (2016)

LEP's leap forward
por: Altarelli, Guido
Publicado: (1989)

The Leap of Your Life
por: Baker, Tommy
Publicado: (2019)

Quantum Leap Year
por: Witty, Nancy
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gdl793qkleok01vqefps5kgbv9